Cargando…
COVID-19-Vaccine-Pfizer-BioNTech/pegfilgrastim/pembrolizumab: Large vessel vasculitis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051817/ http://dx.doi.org/10.1007/s40278-022-14097-5 |
Ejemplares similares
-
Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022) -
“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2021) -
Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech
por: Suzuki, Minami, et al.
Publicado: (2022) -
COVID-19-Vaccine-Pfizer-BioNTech: Thyroiditis: case report
Publicado: (2021)